Search

Author/Creator Hwang, Christopher K.

1. Intravitreous treatment of severe ocular von Hippel–Lindau disease using a combination of the VEGF inhibitor, ranibizumab and PDGF inhibitor, E10030: Results from a phase 1/2 clinical trial. (26th October 2021)

Authors:
Hwang, Christopher K.; Chew, Emily Y.; Cukras, Catherine A.; Keenan, Tiarnan D. L.; Wong, Wai T.; Linehan, W. Marston; Chittiboina, Prashant; Pacak, Karel; Wiley, Henry E.
Journal:
Clinical & experimental ophthalmology
Issue:
Volume 49:Number 9(2021)
Page Start:
1048
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Localized Bilateral Juxtafoveal Photoreceptor Loss in POEMS: A New Association. Issue 7 (July 2017)

Authors:
Hwang, Christopher K.; Kolomeyer, Anton M.; Brucker, Alexander J.; Morgan, Jessica I.W.; Nichols, Charles W.; Aleman, Tomas S.
Other Names:
Toth Cynthia A. section editor.; Walter Scott D. section editor.; Finn Avni P. section editor.
Journal:
Retina
Issue:
Volume 37:Issue 7(2017:Jul.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search